Developing Novel Drug Candidates

Summit Therapeutics is an international biopharmaceutical company focussed on the discovery and development of novel medicines to treat infectious diseases.

Our goal is to become a fully integrated biopharmaceutical company focused on the discovery, development and commercialization of novel medicines for indications for which there are no existing or only inadequate therapies.

We are listed on the AIM market of the London Stock Exchange (symbol ‘SUMM’) and the NASDAQ Global Market (symbol ‘SMMT’).  Further information is available in our dedicated Investor Relations section.

Calendar

ASM Microbe 2018

Click to view our ASM presentations.

Stocks

Share Price

LSE: SUMM
38.50p 0.50
at 04:26pm GMT 13 Jul 2018

NASDAQ: SMMT
$2.41 -0.05
at 04:00pm ET 13 Jul 2018